These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 9384893)

  • 41. Basal ganglia dysfunction in Tourette's syndrome: a new hypothesis.
    Mink JW
    Pediatr Neurol; 2001 Sep; 25(3):190-8. PubMed ID: 11587872
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tardive or atypical Tourette's disorder in a population with Down syndrome?
    Myers B; Pueschel SM
    Res Dev Disabil; 1995; 16(1):1-9. PubMed ID: 7701088
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Tourette's syndrome and antidepressant therapy: exacerbation of nervous tics with paroxetine].
    Rüth U; Mayer-Rosa J; Schlamp D; Freisleder FJ
    Z Kinder Jugendpsychiatr Psychother; 2000 May; 28(2):105-8. PubMed ID: 10863766
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Phenomenology of intentional repetitive behaviors in obsessive-compulsive disorder and Tourette's disorder.
    Miguel EC; Coffey BJ; Baer L; Savage CR; Rauch SL; Jenike MA
    J Clin Psychiatry; 1995 Jun; 56(6):246-55. PubMed ID: 7775367
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Aripiprazole in children with Tourette's disorder and co-morbid attention-deficit/hyperactivity disorder: a 12-week, open-label, preliminary study.
    Masi G; Gagliano A; Siracusano R; Berloffa S; Calarese T; Ilardo G; Pfanner C; Magazù A; Cedro C
    J Child Adolesc Psychopharmacol; 2012 Apr; 22(2):120-5. PubMed ID: 22375853
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Obsessive-compulsive symptomatology in children with Tourette's syndrome.
    Grad LR; Pelcovitz D; Olson M; Matthews M; Grad GJ
    J Am Acad Child Adolesc Psychiatry; 1987 Jan; 26(1):69-73. PubMed ID: 3473061
    [No Abstract]   [Full Text] [Related]  

  • 47. Pharmacotherapeutic challenges in treatment of a child with "the triad" of obsessive compulsive disorder, attention-deficit/hyperactivity disorder and Tourette's disorder.
    Rice T; Coffey B
    J Child Adolesc Psychopharmacol; 2015 Mar; 25(2):176-9. PubMed ID: 25782100
    [No Abstract]   [Full Text] [Related]  

  • 48. Tourette's syndrome: old syndrome, new insights and new treatment.
    Bhidayasiri R
    J Med Assoc Thai; 2005 Sep; 88 Suppl 4():S339-47. PubMed ID: 16623052
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Conceptual and methodological issues in studies of obsessive-compulsive and Tourette's disorders.
    Hollander E; Liebowitz MR; DeCaria CM
    Psychiatr Dev; 1989; 7(4):267-96. PubMed ID: 2577300
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A possible tetracycline-risperidone-sertraline interaction in an adolescent.
    Steele M; Couturier J
    Can J Clin Pharmacol; 1999; 6(1):15-7. PubMed ID: 10465861
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impaired neuropsychological functioning in Tourette's syndrome subjects with co-occurring obsessive-compulsive and attention deficit symptoms.
    de Groot CM; Yeates KO; Baker GB; Bornstein RA
    J Neuropsychiatry Clin Neurosci; 1997; 9(2):267-72. PubMed ID: 9144107
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Neurobiology. Making sense of Tourette's.
    Olson S
    Science; 2004 Sep; 305(5689):1390-2. PubMed ID: 15353772
    [No Abstract]   [Full Text] [Related]  

  • 53. Disentangling the overlap between Tourette's disorder and ADHD.
    Spencer T; Biederman J; Harding M; O'Donnell D; Wilens T; Faraone S; Coffey B; Geller D
    J Child Psychol Psychiatry; 1998 Oct; 39(7):1037-44. PubMed ID: 9804036
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inpatient treatment of obsessive compulsive disorder in childhood: a case study.
    Scahill L; Walker RD; Lechner SN; Tynan KE
    J Child Adolesc Psychiatr Ment Health Nurs; 1993; 6(3):5-14. PubMed ID: 8106978
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impact of obsessive-compulsive symptoms in Tourette's syndrome on neuropsychological performance.
    Matsuda N; Kono T; Nonaka M; Shishikura K; Konno C; Kuwabara H; Shimada T; Kano Y
    Psychiatry Clin Neurosci; 2012 Apr; 66(3):195-202. PubMed ID: 22369455
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clonidine in Tourette's syndrome.
    Cohen DJ; Young JG; Nathanson JA; Shaywitz BA
    Lancet; 1979 Sep; 2(8142):551-3. PubMed ID: 89558
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Diagnosis and treatment of comorbidities of Tourette's syndrome and bipolar disorder in a 10-year-old boy.
    Wang PW; Huang MF; Yen CF; Huang RR
    Kaohsiung J Med Sci; 2009 Nov; 25(11):608-12. PubMed ID: 19858040
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Neurobiology and neuroimmunology of Tourette's syndrome: an update.
    Hoekstra PJ; Anderson GM; Limburg PC; Korf J; Kallenberg CG; Minderaa RB
    Cell Mol Life Sci; 2004 Apr; 61(7-8):886-98. PubMed ID: 15095010
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tics and fits. The current status of Gilles de la Tourette syndrome and its relationship with epilepsy.
    Rickards H
    Seizure; 1995 Dec; 4(4):259-66. PubMed ID: 8719917
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical features distinguishing patients with Tourette's syndrome and obsessive-compulsive disorder from patients with obsessive-compulsive disorder without tics.
    Petter T; Richter MA; Sandor P
    J Clin Psychiatry; 1998 Sep; 59(9):456-9. PubMed ID: 9771815
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.